Ixekizumab for Psoriatic Arthritis: Safety, Efficacy, and Patient Selection

por Miller, John, Puravath, Abin P, Orbai, Ana-Maria
Publicado 2021

A Novel Qualitative Study Assessing Patient-Reported Outcome Measures Among People Living with Psoriatic Arthritis or Ankylosing Spondylitis

por Chakravarty, Soumya D., Abell, Jill, Leone-Perkins, Megan, Orbai, Ana-Maria
Publicado 2021

Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives

por Ly, Karen, Beck, Kristen M, Smith, Mary P, Orbai, Ana-Maria, Liao, Wilson
Publicado 2019

Immune checkpoint inhibitor-induced inflammatory arthritis: a qualitative study identifying unmet patient needs and care gaps

por Cappelli, Laura C., Grieb, Suzanne M., Shah, Ami A., Bingham, Clifton O., Orbai, Ana-Maria
Publicado 2020

Efficacy of Guselkumab in Treating Nails, Scalp, Hands, and Feet in Patients with Psoriasis and Self-reported Psoriatic Arthritis

por Orbai, Ana-Maria, Chakravarty, Soumya D., You, Yin, Shawi, May, Yang, Ya-Wen, Merola, Joseph F.
Publicado 2023

Ixekizumab is efficacious when used alone or when added to conventional synthetic disease-modifying antirheumatic drugs (cDMARDs) in patients with active psoriatic arthritis and pr...

por Nash, Peter, Behrens, Frank, Orbai, Ana-Maria, Rathmann, Suchitrita S, Adams, David H, Benichou, Olivier, Deodhar, Atul
Publicado 2018

Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis

por Gladman, Dafna, Nash, Peter, Goto, Hitoshi, Birt, Julie A, Lin, Chen-Yen, Orbai, Ana-Maria, Kvien, Tore K
Publicado 2020

Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studies

por Orbai, Ana-Maria, Mease, Philip J., Helliwell, Philip S., FitzGerald, Oliver, Fleishaker, Dona L., Mundayat, Rajiv, Young, Pamela
Publicado 2022

Reliability and Validity of Selected PROMIS Measures in People with Rheumatoid Arthritis

por Bartlett, Susan J., Orbai, Ana-Maria, Duncan, Trisha, DeLeon, Elaine, Ruffing, Victoria, Clegg-Smith, Katherine, Bingham, Clifton O.
Publicado 2015

Impact of Enthesitis on Psoriatic Arthritis Patient-Reported Outcomes and Physician Satisfaction with Treatment: Data from a Multinational Patient and Physician Survey

por Orbai, Ana-Maria, Birt, Julie A., Holdsworth, Elizabeth A., Booth, Nicola, Malatestinic, William N., Sprabery, Aubrey T., Reginato, Anthony M.
Publicado 2020

Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies

por Mease, Philip J., Orbai, Ana-Maria, FitzGerald, Oliver, Bedaiwi, Mohamed, Dona L. Fleishaker, Mundayat, Rajiv, Young, Pamela, Helliwell, Philip S.
Publicado 2023

Classification and Outcome Measures for Psoriatic Arthritis

por Leung, Ying Ying, Ogdie, Alexis, Orbai, Ana-Maria, Tillett, William, Coates, Laura C., Strand, Vibeke, Mease, Philip, Gladman, Dafna D.
Publicado 2018

Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients’ health-related quality of life and productivity

por Coates, Laura C., Orbai, Ana-Maria, Morita, Akimichi, Benichou, Olivier, Kerr, Lisa, Adams, David H., Shuler, Catherine L., Birt, Julie, Helliwell, Philip S.
Publicado 2018

Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis

por Gladman, Dafna D., Orbai, Ana-Maria, Klitz, Uta, Wei, James Cheng-Chung, Gallo, Gaia, Birt, Julie, Rathmann, Suchitrita, Shrom, David, Marzo-Ortega, Helena
Publicado 2019

Secukinumab Efficacy on Psoriatic Arthritis GRAPPA-OMERACT Core Domains in Patients with or Without Prior Tumor Necrosis Factor Inhibitor Use: Pooled Analysis of Four Phase 3 Studi...

por Orbai, Ana-Maria, Husni, M. Elaine, Gladman, Dafna D., Leung, Ying Ying, Siebert, Stefan, Tillett, William, Vis, Marijn, Chambenoit, Olivier, Meng, Xiangyi, Mease, Philip J.
Publicado 2021

Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set

por Kalyoncu, Umut, Ogdie, Alexis, Campbell, Willemina, Bingham, Clifton O, de Wit, Maarten, Gladman, Dafna D, Mease, Philip, Steinkoenig, Ingrid, Strand, Vibeke, Riese, Victoria G, Orbai, Ana-Maria
Publicado 2016

Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR)

por Orbai, Ana-Maria, Ogdie, Alexis, Gossec, Laure, Tillett, William, Leung, Ying Ying, Gao, Jingjing, Trivedi, Mona, Tasset, Chantal, Meuleners, Luc, Besuyen, Robin, Hendrikx, Thijs, Coates, Laura C
Publicado 2020

Quantification of pre-existing radiographic damage and its relationship with joint activity and long-term clinical outcomes with secukinumab therapy in patients with psoriatic arth...

por Mease, Philip, van der Heijde, Désirée, Kirkham, Bruce, Schett, Georg, Orbai, Ana-Maria, Ritchlin, Christopher, Merola, Joseph F., Pricop, Luminita, James, David A., Zhu, Xuan, Ligozio, Gregory
Publicado 2022

PROMIS Fatigue short forms are reliable and valid in adults with rheumatoid arthritis

por Bingham III, Clifton O., Gutierrez, Anna Kristina, Butanis, Alessandra, Bykerk, Vivian P., Curtis, Jeffrey R., Leong, Amye, Lyddiatt, Anne, Nowell, W. Benjamin, Orbai, Ana Maria, Bartlett, Susan J.
Publicado 2019

Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis

por Gladman, Dafna D., Orbai, Ana-Maria, Gomez-Reino, Juan, Chang-Douglass, Stacey, Leoncini, Emanuele, Burton, Hannah E., Kanik, Keith S., Romero, Ana Belen, Cappelleri, Joseph C., Hsu, Ming-Ann
Publicado 2020